Metabolic Aspects of Polycystic Ovary Syndrome
August 2015
in “
Postgraduate obstetrics & gynecology
”
Polycystic Ovary Syndrome PCOS insulin resistance dyslipidemia metabolic syndrome type 2 diabetes mellitus nonalcoholic fatty liver disease obstructive sleep apnea cardiovascular disease insulin-sensitizing agents metformin type 2 diabetes fatty liver disease sleep apnea heart disease insulin-sensitizing drugs
Studysummary Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on uu.diva-portal.org →